InsidersTradesSigma
Discover the complete record of transactions filed by Burleson Tess, Director. Director active across 1 companies, notably Salarius Pharmaceuticals, Inc.. Aggregated, 1 reports have been published. Total volume traded: €5k. The latest transaction was filed on 7 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Tess Burleson is a Board Member at Salarius Pharmaceuticals, Inc. She brings expertise in corporate governance and strategy, overseeing operations and contributing to key decision-making. Tess is committed to ensuring the company's success and maximizing shareholder value.